Physician profile
Justin Davis
NPI 1437714375
$2,625.12
in general payments reported to CMS, 2019-2025
7 companies · $604 in 2025
The $604 reported for 2025 was more than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $15.91 · 2022: $1,599 · 2023: $215 · 2024: $190 · 2025: $604.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,010.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,009.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Wardlow Enterprises | $1,200.00 | 2022 | |
| Kerecis Limited | $762.11 | 2022-2025 | Kerecis Surgiclose, Kerecis Omega3 Surgiclose, Kerecis Graftguide |
| Axogen | $269.64 | 2023-2025 | Avance Nerve Graft, Axoguard Nerve Cap, Axoguard Nerve Protector |
| Endo Pharmaceuticals INC. | $123.26 | 2024 | Xiaflex |
| Mentor Worldwide LLC | $108.69 | 2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Allergan, INC. | $95.75 | 2022 | |
| Stryker Corporation | $65.67 | 2021-2024 | Variax |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.